Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
20,100
Employees20,100
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
20,100
Employees20,100

CRL Key Statistics

Market cap
10.67B
Market cap10.67B
Price-Earnings ratio
-141.18
Price-Earnings ratio-141.18
Dividend yield
Dividend yield
Average volume
688.24K
Average volume688.24K
High today
$219.37
High today$219.37
Low today
$214.48
Low today$214.48
Open price
$219.37
Open price$219.37
Volume
427.66K
Volume427.66K
52 Week high
$228.88
52 Week high$228.88
52 Week low
$91.86
52 Week low$91.86

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $216.88. The company's market cap stands at 10.67B, with a P/E ratio of -141.18.

On 2026-01-28, Charles River(CRL) stock moved within a range of $214.48 to $219.37. With shares now at $216.88, the stock is trading +1.1% above its intraday low and -1.1% below the session's peak.

Trading activity shows a volume of 427.66K, compared to an average daily volume of 688.24K.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

CRL News

Simply Wall St 4h
What Charles River Laboratories International's Royalty-Free AAV Plasmid Tie-Up Means For Shareholders

In January 2026, Gazi University Faculty of Medicine and Charles River Laboratories announced a gene therapy CDMO collaboration to supply off-the-shelf, animal...

What Charles River Laboratories International's Royalty-Free AAV Plasmid Tie-Up Means For Shareholders
Simply Wall St 3d
Charles River Labs Reshapes Gene Therapy Role While Legal Risks Linger

Charles River Laboratories International (NYSE:CRL) has entered a new gene therapy collaboration with Gazi University focused on a rare disease program. The co...

Charles River Labs Reshapes Gene Therapy Role While Legal Risks Linger
TipRanks 6d
Charles River price target raised to $251 from $197 at TD Cowen

TD Cowen analyst Charles Rhyee raised the firm’s price target on Charles River (CRL) to $251 from $197 and keeps a Buy rating on the shares. The firm adjusted t...

Analyst ratings

55%

of 20 ratings
Buy
55%
Hold
40%
Sell
5%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.